Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Application crawled date : 2022 - 08 - 01 save search
Krystal Biotech Receives FDA Acceptance of KB407 IND Application for Cystic Fibrosis Clinical Trial
Published: 2022-08-01 (Crawled : 23:00) - biospace.com/
KRYS | $158.63 -3.26% -3.37% 340K
|
Health Technology
|
| O: 1.35%
H: 0.19%
C: -5.15%
kb407 fda fibrosis biotech application trial cystic fibrosis
Krystal Biotech Announces FDA Acceptance of KB407 IND Application for Cystic Fibrosis Clinical Trial
Published: 2022-08-01 (Crawled : 23:00) - globenewswire.com
KRYS | $158.63 -3.26% -3.37% 340K
|
Health Technology
|
| O: -0.8%
H: 5.03%
C: 4.05%
kb407 fda fibrosis biotech application trial cystic fibrosis
What’s New: Automation Actions in the PagerDuty Application for Zendesk by Carrie Lacina
Published: 2022-08-01 (Crawled : 21:00) - pagerduty.com
PD | News | $20.61 -1.06% -0.15% 1M
|
Technology Services
|
| O: -1.85%
H: 4.26%
C: 3.14%
pagerduty application
What’s New: Automation Actions in the PagerDuty Application in Zendesk by Carrie Lacina
Published: 2022-08-01 (Crawled : 20:00) - pagerduty.com
PD | News | $20.61 -1.06% -0.15% 1M
|
Technology Services
|
| O: -1.85%
H: 4.26%
C: 3.14%
pagerduty application
SCYNEXIS Announces U.S. Food and Drug Administration Acceptance and Priority Review of the Supplemental New Drug Application for BREXAFEMME®
Published: 2022-08-01 (Crawled : 13:00) - biospace.com/
SCYX | $1.44 2.49% 2.43% 130K
|
Health Technology
|
| O: -0.43%
H: 6.09%
C: 5.22%
brexafemme drug application review food
SCYNEXIS Announces U.S. Food and Drug Administration Acceptance and Priority Review of the Supplemental New Drug Application for BREXAFEMME® (ibrexafungerp tablets) for Prevention of Recurrent Vaginal Yeast Infections
Published: 2022-08-01 (Crawled : 13:00) - globenewswire.com
SCYX | $1.44 2.49% 2.43% 130K
|
Health Technology
|
| O: -0.43%
H: 6.09%
C: 5.22%
brexafemme drug application infections review food
Beam Therapeutics Announces FDA Clinical Hold on BEAM-201 IND Application
Published: 2022-08-01 (Crawled : 11:00) - globenewswire.com
BEAM | $23.9 -1.69% -1.72% 4.5M
|
Health Technology
|
| O: -8.88%
H: 8.29%
C: 2.53%
beam-201 fda application therapeutics clinical hold
Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubart for the Prevention of Rejection in Kidney Transplant Recipients
Published: 2022-08-01 (Crawled : 10:00) - biospace.com/
ELDN | $1.85 -7.03% -7.57% 420K
|
Manufacturing
|
| O: 3.32%
H: 1.61%
C: -2.57%
fda clearance kidney application
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.